A Pilot Trial of KD018 with Neo-Adjuvant Concurrent Chemo-Radiation Therapy in Patients with Locally Advanced Rectal Cancer
Diseases and Conditions Researched
What is the purpose of this trial?
To investigate the grade 3-4 toxicity associated with a course of neo-adjuvant chemo-radiation with concomitant Capecitabine and KD018 in patients with T3-T4 and N0-N2, M0 rectal cancer
Click here for detailed participation information for this trial.
|Sponsor:||Yale Cancer Center|
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.